Virtual healthcare and physician-focused digital platforms are reshaping U.S. healthcare delivery, with Hims & Hers Health, Inc. HIMS and Doximity, Inc. DOCS at the forefront. Hims & Hers operates a ...

Doximity (DOCS) closed the most recent trading day at $73.60, moving +1.28% from the previous trading session. The stock ...

Doximity, a networking platform for healthcare professionals, announced it acquired Montreal-based Pathway Medical, a company that provides AI-driven clinical decision support, in a deal worth $63 ...

Jeff Tangney's dorm-room project grew into a $13.8 billion enterprise, beloved by physicians. He sat down with Newsweek to ...

Doximity is countersuing hot healthcare startup OpenEvidence after OpenEvidence claimed in June Doximity tried to steal the ...

The Medical Services sector is experiencing significant transformation fueled by advancements in technology, increased adoption of value-based care and focus on patient-centric solutions and precision ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Doximity (DOCS) is a stock that can certainly grab the attention ...

Doximity (DOCS) is rated Hold amid high valuation, growth slowdown, and new AI-driven opportunities. Read here for more ...

The Free Markets ETF portfolio manager, Todd Stankiewicz, joins Yahoo Finance Head of News Myles Udland on Market Domination ...

But the company offers much more than a social network for medical professionals. Rachel Warren: Doximity, I don't know where I've been, but this was just a newer company to me. This isn't one that I ...

Medical technology company Doximity Inc. answered OpenEvidence Inc.'s trade secrets suit with counterclaims alleging an ...

Doximity is reportedly full of false claims posted by physicians stating that covid-19 vaccines are experimental, unproven, or deadly. reading time 3 minutes Medical professionals have become some of ...